AXYNTIS Group employs nearly 400 people and operates 3 cGMP manufacturing sites in France (2 are also FDA inspected and accredited by PMDA). We provide/offer comprehensive CDMO services to our partners for their API or advanced intermediates projects from early-stage development to commercial phase, including preparative chromatography (KYRAPHARM subsidiary). We also commercialize a range of proprietary API and building blocks.